Larimar Therapeutics logo

Larimar Therapeutics LRMR

$ 4.66 3.67%

Annual report 2025
added 03-19-2026

report update icon

Country

usaUSA

IPO year

2014

Industry

Biotechnology

Stock Exchange

NASDAQ GLOBAL

Shares

83.1 M

Market Cap[1]

$ 387 M

EBITDA (LTM)

$ -63.6 M

P/E (LTM)

-2.61

P/S (LTM)

-

EPS (LTM)

-1.72

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Amgen Amgen
AMGN
$ 350.62 0.81 % $ 189 B Nasdaq Global Select Market,SPB usaUSA
Heron Therapeutics Heron Therapeutics
HRTX
$ 0.8 2.35 % $ 133 M Nasdaq Global Select Market,SPB usaUSA
Altimmune Altimmune
ALT
$ 3.46 3.44 % $ 305 M Nasdaq Global Market usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Genfit SA Genfit SA
GNFT
- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 219.42 -1.11 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Incyte Corporation Incyte Corporation
INCY
$ 90.74 -0.04 % $ 17.7 B Nasdaq Global Select Market,SPB usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Inovio Pharmaceuticals Inovio Pharmaceuticals
INO
$ 1.62 2.22 % $ 35.9 M Nasdaq Global Select Market usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M Nasdaq Global Market israelIsrael
Cullinan Management Cullinan Management
CGEM
$ 12.92 1.41 % $ 778 M Nasdaq Global Select Market usaUSA
Inventiva S.A. Inventiva S.A.
IVA
$ 6.13 6.06 % $ 138 M Nasdaq Global Market franceFrance
Atreca Atreca
BCEL
- -11.76 % $ 5.79 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
$ 16.76 -1.41 % $ 832 M Nasdaq Global Select Market britainBritain
Calithera Biosciences Calithera Biosciences
CALA
- -10.95 % $ 876 K Nasdaq Global Select Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChemoCentryx ChemoCentryx
CCXI
- - $ 3.74 B Nasdaq Global Select Market,SPB usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
- -74.18 % $ 955 K Nasdaq Capital Market usaUSA
Kamada Ltd. Kamada Ltd.
KMDA
$ 8.23 -0.24 % $ 260 M Nasdaq Global Select Market israelIsrael
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
- - $ 169 M Nasdaq Capital Market usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
$ 7.06 -7.47 % $ 860 K Nasdaq Global Select Market usaUSA
Clovis Oncology Clovis Oncology
CLVS
- -7.23 % $ 13 M Nasdaq Global Select Market usaUSA
Keros Therapeutics Keros Therapeutics
KROS
$ 11.27 2.83 % $ 419 M Nasdaq Global Select Market usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M Nasdaq Global Market germanyGermany
Denali Therapeutics Denali Therapeutics
DNLI
$ 21.23 5.26 % $ 3.49 B Nasdaq Global Select Market,SPB usaUSA
Longeveron Longeveron
LGVN
$ 0.95 -3.52 % $ 16.7 B Nasdaq Global Select Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Arbutus Biopharma Corporation Arbutus Biopharma Corporation
ABUS
$ 4.3 1.3 % $ 714 M Nasdaq Global Select Market canadaCanada
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.